SMTL ID : 9klc.1

G9a in complex with the S-isomer of RK-131902 (racemic compound rac-10a)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.15 Å
Oligo State
homo-dimer
Ligands
8 x ZN: ZINC ION(Non-covalent)
2 x SFG: SINEFUNGIN(Non-covalent)
2 x 01: ~{N}-[(2~{S})-1-[[6-(1-methylpiperidin-4-yl)oxypyridin-3-yl]amino]-1-oxidanylidene-hexan-2-yl]-3-(pyridin-4-ylamino)benzamide
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nishigaya, Y. et al., Discovery of potent substrate-type lysine methyltransferase G9a inhibitors for the treatment of sickle cell disease. Eur.J.Med.Chem. (2025)
Release Date
2025-05-21
Peptides
Histone-lysine N-methyltransferase EHMT2: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Histone-lysine N-methyltransferase EHMT2

Related Entries With Identical Sequence

3k5k.1 | 3k5k.2 | 3k5k.3 | 3rjw.1 | 5ttf.1 | 5ttf.2 | 5v9i.1 | 5v9i.2 | 7btv.1 | 7buc.1 | 7dcf.1 | 7t7l.1 | 7t7l.2 | 7x73.1 | 7xua.1 | 7xub.1 | 7xuc.1 | 7xud.1 | 8z7c.1 | 8z7d.1 | 8z7e.1 | 9klb.1